Healthcare -
Biotechnology - NASDAQ - US
$ 1.185
-1.25 %
$ 76.1 M
Market Cap
-0.76
P/E
INZY - DEPRECIATION & AMORTIZATION
Depreciation & Amortization INZY - Inozyme Pharma, Inc.
833 K
LAST VALUE
11.17%
2 YEAR CAGR
100.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR